IL91778A - A method for reducing the heterogeneity of monoclonal antibodies - Google Patents
A method for reducing the heterogeneity of monoclonal antibodiesInfo
- Publication number
- IL91778A IL91778A IL9177889A IL9177889A IL91778A IL 91778 A IL91778 A IL 91778A IL 9177889 A IL9177889 A IL 9177889A IL 9177889 A IL9177889 A IL 9177889A IL 91778 A IL91778 A IL 91778A
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- incubation
- heterogeneity
- culture
- hours
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25078688A | 1988-09-28 | 1988-09-28 | |
| US25078788A | 1988-09-28 | 1988-09-28 | |
| US25078888A | 1988-09-28 | 1988-09-28 | |
| US07/364,056 US5126250A (en) | 1988-09-28 | 1989-06-09 | Method for the reduction of heterogeneity of monoclonal antibodies |
| CA000613379A CA1332367C (fr) | 1988-09-28 | 1989-09-26 | Methode de reduction de l'heterogeneite d'anticorps monoclonaux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL91778A true IL91778A (en) | 1994-10-07 |
Family
ID=27508376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9177889A IL91778A (en) | 1988-09-28 | 1989-09-26 | A method for reducing the heterogeneity of monoclonal antibodies |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0361902B1 (fr) |
| JP (1) | JP2925181B2 (fr) |
| CN (1) | CN1041392A (fr) |
| AR (1) | AR242986A1 (fr) |
| AT (1) | ATE101876T1 (fr) |
| AU (1) | AU615576B2 (fr) |
| BG (1) | BG60017B2 (fr) |
| CA (1) | CA1332367C (fr) |
| DE (1) | DE68913251T2 (fr) |
| DK (1) | DK475389A (fr) |
| ES (1) | ES2049332T3 (fr) |
| IE (1) | IE63562B1 (fr) |
| IL (1) | IL91778A (fr) |
| MX (1) | MX170441B (fr) |
| NZ (1) | NZ230786A (fr) |
| PL (1) | PL162260B1 (fr) |
| RO (1) | RO105652B1 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104761637B (zh) | 2006-03-31 | 2021-10-15 | 中外制药株式会社 | 调控抗体血液动力学的方法 |
| EP1878747A1 (fr) | 2006-07-11 | 2008-01-16 | greenovation Biotech GmbH | Anticorps glyco-modifiés |
| EP2031064A1 (fr) * | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Procédé d'augmentation de titres de protéines |
| ES2595638T3 (es) | 2007-09-26 | 2017-01-02 | Chugai Seiyaku Kabushiki Kaisha | Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR |
| KR101680906B1 (ko) | 2007-09-26 | 2016-11-30 | 추가이 세이야쿠 가부시키가이샤 | 항체 정상영역 개변체 |
| KR102057826B1 (ko) | 2008-04-11 | 2019-12-20 | 추가이 세이야쿠 가부시키가이샤 | 복수 분자의 항원에 반복 결합하는 항원 결합 분자 |
| TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| JP5717624B2 (ja) | 2009-03-19 | 2015-05-13 | 中外製薬株式会社 | 抗体定常領域改変体 |
| EP2826789A1 (fr) | 2009-03-19 | 2015-01-21 | Chugai Seiyaku Kabushiki Kaisha | Variant d'une région constante d'anticorps |
| EP2647706B1 (fr) | 2010-11-30 | 2023-05-17 | Chugai Seiyaku Kabushiki Kaisha | Molécule de liaison à l'antigène, apte à se lier de façon répétée à une pluralité de molécules d'antigène |
| CN103282509A (zh) * | 2010-12-28 | 2013-09-04 | 中外制药株式会社 | 动物细胞的培养方法 |
| PL3489254T3 (pl) | 2012-04-30 | 2023-01-30 | Biocon Limited | Ukierunkowujące/immunomodulujące białko fuzyjne i sposoby jego otrzymywania |
| CA2902830C (fr) | 2013-03-12 | 2023-09-19 | Biocon Ltd. | Proteines de fusion immunomodulatrices et leurs procedes de fabrication |
| US10782290B2 (en) | 2013-06-11 | 2020-09-22 | National Center Of Neurology And Psychiatry | Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy |
| CA2972393A1 (fr) | 2015-02-27 | 2016-09-01 | Chugai Seiyaku Kabushiki Kaisha | Composition pour le traitement de maladies associees a il-6 |
| US10697883B2 (en) | 2015-05-19 | 2020-06-30 | National Center Of Neurology And Psychiatry | Method for determining application of therapy to multiple sclerosis (MS) patient |
| HRP20210830T1 (hr) * | 2016-10-17 | 2021-08-20 | Enzene Biosciences Ltd. | Kontinuirani proces smanjenja heterogenosti terapijskog proteina |
| WO2018203545A1 (fr) | 2017-05-02 | 2018-11-08 | 国立研究開発法人国立精神・神経医療研究センター | Procédé de prédiction et d'évaluation d'un effet thérapeutique dans des maladies associées à il-6 et à des neutrophiles |
| JP7235249B2 (ja) | 2017-10-20 | 2023-03-08 | 学校法人兵庫医科大学 | 抗ｉｌ－６受容体抗体を含有する術後の癒着を抑制するための医薬組成物 |
| WO2019151418A1 (fr) | 2018-01-31 | 2019-08-08 | 元一 加藤 | Agent thérapeutique pour l'asthme contenant un inhibiteur d'il-6 |
| EP3957324A4 (fr) | 2019-04-17 | 2023-02-08 | Hiroshima University | Agent thérapeutique pour cancer urologique caractérisé en ce qu'il est administré avec un inhibiteur de il-6 et un inhibiteur de ccr2 en combinaison |
| EP4159236A4 (fr) | 2020-05-29 | 2024-08-21 | Chugai Seiyaku Kabushiki Kaisha | Formulation contenant un anticorps |
-
1989
- 1989-09-26 IL IL9177889A patent/IL91778A/en not_active IP Right Cessation
- 1989-09-26 BG BG089846A patent/BG60017B2/bg unknown
- 1989-09-26 NZ NZ230786A patent/NZ230786A/xx unknown
- 1989-09-26 CA CA000613379A patent/CA1332367C/fr not_active Expired - Fee Related
- 1989-09-26 RO RO141765A patent/RO105652B1/ro unknown
- 1989-09-26 AR AR89310004A patent/AR242986A1/es active
- 1989-09-27 AU AU42343/89A patent/AU615576B2/en not_active Ceased
- 1989-09-27 ES ES89309851T patent/ES2049332T3/es not_active Expired - Lifetime
- 1989-09-27 DK DK475389A patent/DK475389A/da not_active Application Discontinuation
- 1989-09-27 DE DE68913251T patent/DE68913251T2/de not_active Expired - Fee Related
- 1989-09-27 IE IE309489A patent/IE63562B1/en not_active IP Right Cessation
- 1989-09-27 EP EP89309851A patent/EP0361902B1/fr not_active Expired - Lifetime
- 1989-09-27 MX MX017721A patent/MX170441B/es unknown
- 1989-09-27 PL PL89281598A patent/PL162260B1/pl unknown
- 1989-09-27 AT AT89309851T patent/ATE101876T1/de not_active IP Right Cessation
- 1989-09-28 JP JP1256890A patent/JP2925181B2/ja not_active Expired - Fee Related
- 1989-09-28 CN CN89107508.9A patent/CN1041392A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AR242986A1 (es) | 1993-06-30 |
| EP0361902A3 (en) | 1990-08-16 |
| JP2925181B2 (ja) | 1999-07-28 |
| MX170441B (es) | 1993-08-23 |
| EP0361902A2 (fr) | 1990-04-04 |
| BG60017B2 (bg) | 1993-06-30 |
| CA1332367C (fr) | 1994-10-11 |
| IE63562B1 (en) | 1995-05-17 |
| DK475389A (da) | 1990-03-29 |
| AU4234389A (en) | 1990-04-05 |
| ATE101876T1 (de) | 1994-03-15 |
| RO105652B1 (ro) | 1992-11-30 |
| EP0361902B1 (fr) | 1994-02-23 |
| ES2049332T3 (es) | 1994-04-16 |
| PL162260B1 (pl) | 1993-09-30 |
| DE68913251D1 (de) | 1994-03-31 |
| NZ230786A (en) | 1991-11-26 |
| DK475389D0 (da) | 1989-09-27 |
| JPH02163096A (ja) | 1990-06-22 |
| AU615576B2 (en) | 1991-10-03 |
| DE68913251T2 (de) | 1994-06-23 |
| CN1041392A (zh) | 1990-04-18 |
| IE893094L (en) | 1990-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5126250A (en) | Method for the reduction of heterogeneity of monoclonal antibodies | |
| EP0361902B1 (fr) | Méthode pour la réduction de l'hétérogénéité des anticorps monoclonaux | |
| RU2252961C2 (ru) | Способ получения амидированного пептида | |
| US4954437A (en) | Cell encoding recombinant human erythropoietin | |
| KR0157983B1 (ko) | 아미드화 효소 발현계 | |
| KR910006602B1 (ko) | 면역 인터페론의 제조방법 | |
| CA2280791A1 (fr) | Detection immunologique de prions | |
| WO1986004336A1 (fr) | Anticorps monoclonaux contre les proteines de noyau de virus associes aux lymphadenopathies | |
| JPH0638743A (ja) | 抗プロテインｃモノクローナル抗体およびそれを産生するハイブリドーマ | |
| EP0162034B1 (fr) | Méthode pour isoler des anticorps monoclonaux de cultures d'hybridomes | |
| EP0169239A1 (fr) | CLONES DE cADN D'ERYTHROPOIETINE HUMAINE | |
| KR960013460B1 (ko) | 안티-pci 모노클로날 항체 | |
| EP0132021B1 (fr) | Polypeptides TGF, oligopeptidiques antigéniques dérivés de ceux-ci, anticorps produits de ceux-ci | |
| EP0519728A2 (fr) | Anticorps monoclonaux anti-TCF-II et leur application dans le dosage de TCF-II | |
| JPH09235300A (ja) | ヒトｔｉｍｐ−３及び抗ヒトｔｉｍｐ−３モノクローナル抗体並びにその用途 | |
| Ishizuka et al. | Characterization of monoclonal antibodies against human prorenin profragment and identification of active prorenins in plasma | |
| JP4361579B2 (ja) | コンドロイチナーゼａｂｃに対するモノクローナル抗体 | |
| EP0559428B1 (fr) | Nouveaux polypeptides et ADNs codant pour ceux-ci | |
| Wunderlich et al. | Use of recombinant fusion proteins for generation and rapid characterization of monoclonal antibodies: Application to the Kunitz domain of human β amyloid precursor protein | |
| JPS61221128A (ja) | プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法 | |
| JP4090486B2 (ja) | コンドロイチン硫酸リアーゼｉｉに対するモノクローナル抗体 | |
| JP4361578B2 (ja) | コンドロイチン硫酸リアーゼｉｉに対するモノクローナル抗体 | |
| AU752369B2 (en) | TNF-alpha converting enzyme | |
| JPS63253098A (ja) | ヒト抗体に対するモノクロ−ナル抗体、その製法及び用途 | |
| JPS62236494A (ja) | シグナルペプチダ−ゼに対するモノクロ−ナル抗体、およびそれを産生するハイブリド−マ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |